Zhejiang Provincial People's Hospital

This study tests two drugs, sacituzumab tirumotecan and tislelizumab, in people with advanced thyroid cancer that has stopped responding to standard treatments. The goal is to see if these drugs can shrink tumors or help people live longer. About 94 adults with three types of har…

This study tests whether adding low-dose radiation and an immunotherapy drug (pultelimab) to standard treatment can help control advanced pancreatic cancer. Ten adults with pancreatic cancer who have not had prior immunotherapy or radiation will receive the combination. The goal …

This study tests whether combining two drugs, telitacicept and baricitinib, can help people with difficult-to-treat rheumatoid arthritis (D2T RA) who have not responded to other treatments. About 30 adults aged 18-85 will receive the combination and be monitored for joint disease…

This study compares a new once-daily combination pill (henagliflozin plus metformin) against standard metformin pills in 268 adults recently diagnosed with type 2 diabetes. The goal is to see if the combo pill better controls blood sugar, helps with weight loss, and increases the…